ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,201,494 | +2.9% | 633,469 | +18.3% | 0.07% | +7.8% |
| Q2 2023 | $12,827,165 | +36.8% | 535,581 | +7.5% | 0.06% | +25.5% |
| Q1 2023 | $9,375,710 | +20.3% | 498,178 | +1.8% | 0.05% | +13.3% |
| Q4 2022 | $7,793,572 | -6.6% | 489,546 | -4.0% | 0.04% | -18.2% |
| Q3 2022 | $8,342,000 | +290.7% | 509,921 | +236.5% | 0.06% | +323.1% |
| Q2 2022 | $2,135,000 | +52.9% | 151,516 | +162.9% | 0.01% | +85.7% |
| Q1 2022 | $1,396,000 | -18.6% | 57,635 | -48.7% | 0.01% | -30.0% |
| Q2 2018 | $1,715,000 | +419.7% | 112,325 | +980.0% | 0.01% | +233.3% |
| Q4 2014 | $330,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |